Diuretics
PREPARED BY : DR M YOUNAS
 Definition : Drugs that increase the excretion of water and electrolytes from the
body by enhancing urine output.
 General function
 Reduce extracellular fluid volume
 Lower blood pressure
 Relieve edema
Classification (MOA-based)
 Carbonic anhydrase inhibitors
 Osmotic diuretics
 Loop diuretics
 Thiazide diuretics
 Potassium sparing diuretics
Carbonic Anhydrase Inhibitors
(CAIs)
 Example : Acetazolamide
 Site of action : Proximal tubules
 MOA : MOA: Inhibit carbonic anhydrase → ↓ H secretion → ↓ Na
⁺ ⁺
reabsorption → ↑ HCO and water loss
₃⁻
 Clinical uses:
 Glaucoma (↓ aqueous humor production)
 Acute mountain sickness (↓ CSF production)
 Metabolic alkalosis
 Side effects: Metabolic acidosis, blurred vision, hypokalemia,
paresthesia
Osmotic Diuretics
 Example: Mannitol (IV only)
 Site of action: Proximal tubule & descending loop of Henle
 MOA: Inert substance → increases osmotic pressure → prevents
water reabsorption
 Clinical uses:
 Cerebral edema
 Acute glaucoma
 Oliguric acute renal failure
 Side effects: Pulmonary edema (in CHF), dehydration,
hypernatremia
Loop Diuretics
 Examples: Furosemide, Bumetanide, Torsemide
 Site of action: Thick ascending limb of loop of Henle
 MOA: Inhibit Na -K -2Cl cotransporter → very strong diuresis → loss of Na , K , Cl ,
⁺ ⁺ ⁻ ⁺ ⁺ ⁻
Ca² , Mg²
⁺ ⁺
 Clinical uses:
 Pulmonary edema (fast action)
 CHF with volume overload
 Hypertension (when resistant to thiazides)
 Hypercalcemia (promotes Ca² loss)
⁺
 Side effects: Hypokalemia, hypocalcemia, metabolic alkalosis, ototoxicity, gout
(↑ uric acid)
Thiazide Diuretics
 Examples: Hydrochlorothiazide, Chlorthalidone, Indapamide
 Site of action: Distal convoluted tubule
 MOA: Inhibit Na -Cl symporter → moderate diuresis → retain Ca²
⁺ ⁻ ⁺
 Clinical uses:
 First-line in hypertension
 CHF (mild)
 Nephrogenic diabetes insipidus (↓ urine volume)
 Prevention of kidney stones (↓ Ca² excretion)
⁺
 Side effects: Hypokalemia, hyponatremia, hyperglycemia, hyperlipidemia,
hyperuricemia (gout), hypercalcemia
Potassium-Sparing Diuretics
 Examples:
Spironolactone, Eplerenone (aldosterone antagonists) Amiloride, Triamterene
(ENaC blockers)
 Site of action: Collecting duct
 MOA:
Block aldosterone receptors (spironolactone)
Or block Na channels (amiloride, triamterene) → ↓ Na reabsorption & ↓ K
⁺ ⁺ ⁺
secretion
 Clinical uses:
 CHF (↓ mortality with spironolactone)
 Resistant hypertension
 Primary hyperaldosteronism
 Side effects: Hyperkalemia, metabolic acidosis, gynecomastia (spironolactone)
General Clinical Uses of Diuretics
 Hypertension (thiazides = first-line)
 Congestive heart failure (loops, K -sparing)
⁺
 Renal diseases with edema (loops)
 Cirrhosis with ascites (spironolactone)
 Glaucoma (acetazolamide, mannitol)
 Raised intracranial pressure (mannitol)
Thank You

New Microsoft PowerPoint Presentation.pptx

  • 1.
  • 3.
     Definition :Drugs that increase the excretion of water and electrolytes from the body by enhancing urine output.  General function  Reduce extracellular fluid volume  Lower blood pressure  Relieve edema
  • 4.
    Classification (MOA-based)  Carbonicanhydrase inhibitors  Osmotic diuretics  Loop diuretics  Thiazide diuretics  Potassium sparing diuretics
  • 6.
    Carbonic Anhydrase Inhibitors (CAIs) Example : Acetazolamide  Site of action : Proximal tubules  MOA : MOA: Inhibit carbonic anhydrase → ↓ H secretion → ↓ Na ⁺ ⁺ reabsorption → ↑ HCO and water loss ₃⁻  Clinical uses:  Glaucoma (↓ aqueous humor production)  Acute mountain sickness (↓ CSF production)  Metabolic alkalosis  Side effects: Metabolic acidosis, blurred vision, hypokalemia, paresthesia
  • 7.
    Osmotic Diuretics  Example:Mannitol (IV only)  Site of action: Proximal tubule & descending loop of Henle  MOA: Inert substance → increases osmotic pressure → prevents water reabsorption  Clinical uses:  Cerebral edema  Acute glaucoma  Oliguric acute renal failure  Side effects: Pulmonary edema (in CHF), dehydration, hypernatremia
  • 8.
    Loop Diuretics  Examples:Furosemide, Bumetanide, Torsemide  Site of action: Thick ascending limb of loop of Henle  MOA: Inhibit Na -K -2Cl cotransporter → very strong diuresis → loss of Na , K , Cl , ⁺ ⁺ ⁻ ⁺ ⁺ ⁻ Ca² , Mg² ⁺ ⁺  Clinical uses:  Pulmonary edema (fast action)  CHF with volume overload  Hypertension (when resistant to thiazides)  Hypercalcemia (promotes Ca² loss) ⁺  Side effects: Hypokalemia, hypocalcemia, metabolic alkalosis, ototoxicity, gout (↑ uric acid)
  • 9.
    Thiazide Diuretics  Examples:Hydrochlorothiazide, Chlorthalidone, Indapamide  Site of action: Distal convoluted tubule  MOA: Inhibit Na -Cl symporter → moderate diuresis → retain Ca² ⁺ ⁻ ⁺  Clinical uses:  First-line in hypertension  CHF (mild)  Nephrogenic diabetes insipidus (↓ urine volume)  Prevention of kidney stones (↓ Ca² excretion) ⁺  Side effects: Hypokalemia, hyponatremia, hyperglycemia, hyperlipidemia, hyperuricemia (gout), hypercalcemia
  • 10.
    Potassium-Sparing Diuretics  Examples: Spironolactone,Eplerenone (aldosterone antagonists) Amiloride, Triamterene (ENaC blockers)  Site of action: Collecting duct  MOA: Block aldosterone receptors (spironolactone) Or block Na channels (amiloride, triamterene) → ↓ Na reabsorption & ↓ K ⁺ ⁺ ⁺ secretion  Clinical uses:  CHF (↓ mortality with spironolactone)  Resistant hypertension  Primary hyperaldosteronism  Side effects: Hyperkalemia, metabolic acidosis, gynecomastia (spironolactone)
  • 11.
    General Clinical Usesof Diuretics  Hypertension (thiazides = first-line)  Congestive heart failure (loops, K -sparing) ⁺  Renal diseases with edema (loops)  Cirrhosis with ascites (spironolactone)  Glaucoma (acetazolamide, mannitol)  Raised intracranial pressure (mannitol)
  • 12.